Prospective Study of Active Pain Management in Lung Cancer Outpatients (APM)
APM
A Randomized Prospective Controlled Study of Active Pain Management in Lung Cancer Outpatients (APM)
1 other identifier
interventional
79
1 country
1
Brief Summary
This study is:
- A single-center, randomized, prospective controlled trial.
- To prove superiority of active pain management group compared to control group by the percent of pain intensity difference of outpatients with lung cancer pain.
- 204 patients will be recruited.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3 lung-cancer
Started Jan 2011
Shorter than P25 for phase_3 lung-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedFirst Submitted
Initial submission to the registry
February 1, 2011
CompletedFirst Posted
Study publicly available on registry
March 8, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2012
CompletedFebruary 5, 2016
February 1, 2016
1 year
February 1, 2011
February 4, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The percent of pain intensity difference
The percent of pain intensity difference (%PID) %PID = (NRS of visit 1 - NRS of visit 3)/NRS of visit 1
visit 3 (6 to 8 weeks)
Secondary Outcomes (4)
Patients' satisfaction score about pain management
visit 3 (6 to 8 weeks)
Eastern Cooperative Oncology Group (ECOG) Performance score
visit 3 (6 to 8 weeks)
Assessment of Korean Brief Pain Inventory score
visit 3 (6 to 8 weeks)
Investigator's global assessment score
visit 3 (6 to 8 weeks)
Study Arms (1)
active pain management
EXPERIMENTALactive pain management (APM) by specialized nurses for cancer pain
Interventions
Active pain management will be provided by specialized pain nurse, such as telephone counseling for toxicity control and opioid dose modification.
Eligibility Criteria
You may qualify if:
- Outpatients with lung cancer.
- The patients with uncontrolled lung cancer pain - more than and equal NRS 4 pain during previous 24 hours for background pain, or more than and equal 3 times/day for breakthrough painkiller medication.
- Over 20 year-old male or female.
- The patients can be able to received telephone counseling by investigator's decision.
You may not qualify if:
- Drug or alcohol abusers.
- Child-bearing women or pregnant women.
- The patients with moderate to severe psychiatric problems.
- The patients who have hypersensitivity to opioids.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Chonnam National University Hospitallead
- Janssen Korea, Ltd., Koreacollaborator
Study Sites (1)
Chonnam National University Hwasun Hospital
Jeonnam, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Young-Chul Kim, MD,PhD
Chonnam National University Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 1, 2011
First Posted
March 8, 2011
Study Start
January 1, 2011
Primary Completion
January 1, 2012
Study Completion
June 1, 2012
Last Updated
February 5, 2016
Record last verified: 2016-02